Promising anti-leukemic activity of atorvastatin

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 2065-2071

  Zołnierczyk, Jolanta D ^a   Borowiak, Arleta ^a   Hikisz, Paweł ^a   Cebula Obrzut, Barbara ^b   Błoński, Jerzy Z ^b   Smolewski, Piotr ^b   Robak, Tadeusz ^b   Kiliańska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Anticancer agents; Apoptosis; Apoptosis related proteins; Atorvastatin; Chronic lymphocytic leukemia; DNA fragmentation

Indexed keywords

ATORVASTATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; LAMIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ANTILEUKEMIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL COUNT; CELL CYCLE G1 PHASE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MITOCHONDRIAL PERMEABILITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA FRAGMENTATION; FEMALE; HEPTANOIC ACIDS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84876243669     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2301     Document Type: Article

References (39)

1. Eichhorst B, Dreyling M, Robak T, Montserrat E and Hallek M; ESMO Guidelines Working Group: Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22 (Suppl 6): vi50-vi54, 2011.
2. Brenner H, Gondos A and Pulte D: Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 111: 4916-4921, 2008.
3. Kiliańska ZM and Rogalińska M: Potential new agents for chronic lymphocytic leukemia treatment. Anticancer Agents Med Chem 10: 666-682, 2010.
4. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M and Kipps TJ: Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96: 2655-2663, 2000.
5. Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F and Peschel C: Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 101: 278-285, 2003. (Pubitemid 36025919)
6. Zhou Q and Liao JK: Pleiotropic effects of statins. Basic research and clinical perspectives. Circ J 74: 818-826, 2010.
7. Roy M, Kung HJ and Ghosh PM: Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins. Am J Cancer Res 1: 542-561, 2011.
8. Chapman-Shimshoni D, Yuklea M, Radnay J, Shapiro H and Lishner M: Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol 31: 779-783, 2003. (Pubitemid 37075970)
9. Pahan K: Lipid-lowering drugs. Cell Mol Life Sci 63: 1165-1167, 2006.
10. Copajaa M, Venegasa D, Aránguiza P, et al: Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts. Toxicol Appl Pharmacol 255: 57-64, 2011.
11. Wong WW, Dimitroulakos J, Minden MD and Penn LZ: HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16: 508-519, 2002. (Pubitemid 34460459)
12. Chan KK, Oza AM and Siu LL: The statins as anticancer agents. Clin Cancer Res 9: 10-19, 2003. (Pubitemid 36109711)
13. Agarwal B, Halmos B, Feoktistov AS, et al: Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis 23: 521-528, 2002. (Pubitemid 34257633)
14. van de Donk NW, Schotte D, Kamphuis MM, van Marion AM, van Kessel B, Bloem AC and Lokhorst HM: Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells. Clin Cancer Res 9: 5735-5748, 2003. (Pubitemid 37499498)
15. Sleiffer S, van der Gaast A, Planting AS, Stoter G and Verweij J: The potential of statins as part of anti-cancer treatment. Eur J Cancer 41: 516-522, 2005. (Pubitemid 40292731)
16. Zhuang L, Kim J, Adam RM, Solomon KR and Freeman MR: Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115: 959-968, 2005. (Pubitemid 40489400)
17. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN and Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-234, 1975.
18. Kobylinska A, Bednarek J, Blonski JZ, Hanausek M, Walaszek Z, Robak T and Kilianska ZM: In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone. Oncol Rep 16: 1389-1395, 2006.
19. Bellosillo B, Villamor N, Colomer D, Pons G, Montserrat E and Gil J: In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood 94: 2836-2843, 1998.
20. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
21. Towbin H, Staechlin T and Gordon J: Electrophoretic transer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979. (Pubitemid 9256559)
22. Kajstura M, Halicka HD, Pryjma J and Darzynkiewicz Z: Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete 'sub-G1' peaks on DNA content histograms. Cytometry A 71: 125-131, 2007. (Pubitemid 46355337)
23. Kim J-S, Pirnia F, Choi YH, et al: Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint. Oncogene 19: 6082-6090, 2000. (Pubitemid 32039383)
24. Podhorecka M, Halicka D, Klimek P, Kowal M, Chocholska S and Dmoszyńska A: Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. Ann Hematol 89: 1115-1124, 2010.
25. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F and Wang X: Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475-1486, 2003. (Pubitemid 36734705)
26. Johnston JB, Paul JT, Neufeld NJ, et al: Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. Leuk Lymphoma 45: 2017-2027, 2004. (Pubitemid 39232850)
27. Kobylinska A, Blonski JZ, Hanausek M, Walaszek Z, Robak T and Kilianska ZM: Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells. Oncol Rep 11: 699-705, 2004.
28. Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K and Sheridan DP: Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Am J Hematol 75: 22-33, 2004. (Pubitemid 38040164)
29. Muzio M, Apollonio B, Scielzo C, et al: Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 112: 188-195, 2008.
30. Grzybowska-Izydorczyk O, Cebula B, Robak T and Smolewski P: Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia. Eur J Cancer 46: 800-810, 2010.
31. Salman H, Bergman M, Djaldetti M and Bessler H: Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro. Biomed Pharmacother 62: 41-45, 2008.
32. McConkey DJ: Calcium-dependent, interleukin 1-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei. J Biol Chem 271: 22398-22406, 1996.
33. Garnier P, Ying W and Swanson RA: Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J Neurosci 23: 7967-7973, 2003. (Pubitemid 37082448)
34. Kip1 in chronic B-cell lymphocytic leukemia. Blood 91: 4694-4700, 1998.
35. Kip1 mediates its antiapoptotic activity. Oncogene 18: 4839-4847, 1999.
36. Zolnierczyk JD, Błoński JZ, Robak T, Kiliańska ZM and Wesierska-Gadek J: Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. Ann NY Acad Sci 1171: 124-131, 2009.
37. Borner C: The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39: 615-647, 2003.
38. Skommer J, Wlodkowic D and Deptala A: Larger than life: mitochondria and the Bcl-2 family. Leuk Res 31: 277-286, 2007. (Pubitemid 46073182)
39. Osmak M: Statin and cancer: current and future prospects. Cancer Lett 324: 1-12, 2012.